Enovis Corporation (ENOV)

Market Cap	2.71B
Revenue (ttm)	1.56B
Net Income (ttm)	-13.29M
Shares Out	54.33M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	22.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	517,212
Open	49.06
Previous Close	49.50
Day's Range	48.70 - 50.03
52-Week Range	43.88 - 72.13
Beta	2.09
Analysts	Buy
Price Target	64.26 (+28.7%)
Earnings Date	May 9, 2023

About ENOV

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therap...

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• IPO Date: May 8, 2008
• Employees: 16,200
• Stock Exchange: NYSE
• Ticker Symbol: ENOV

Analyst Forecast

According to 14 analysts, the average rating for ENOV stock is "Buy." The 12-month stock price forecast is $64.26, which is an increase of 28.70% from the latest price.

Price Target

$64.26

(28.70% upside)

Analyst Consensus: Buy